We studied the electrophysiological and antiarrhythmic actions of 3,4,quinoline-3,4-dione], a furoquinoline alkaloid derivative, in guinea pig heart preparations. In the perfused whole heart model, HA-7 caused a prolongation in the basic cycle length, ventricular repolarization time, and the atrioventricular (AV) nodal Wenckebach cycle length and prolonged the refractory period of the atrium, AV node, and His-Purkinje system. The atrioventricular conduction interval was also prolonged in a frequency-dependent manner. In isolated hearts, HA-7 significantly raised the threshold for experimental atrial fibrillation and reduced the occurrence of reperfusion-induced ventricular fibrillation. Conventional microelectrode-recording study shows that HA-7, but not d-sotalol, prolonged the action potential duration (APD) and decreased the maximum rate of depolarization in isolated atrial strips. In ventricular papillary muscles, higher concentrations of HA-7 caused a prolongation of APD 90 in a frequency-independent manner, whereas d-sotalol exerted a reverse frequency-dependent action on this parameter. Whole-cell patch clamp results on ventricular myocytes indicate that HA-7 decreased both the slow (I Ks ) (IC 50 ϭ 4.8 M) and fast component (I Kr ) (IC 50 ϭ 1
ϩ inward current (I Na ) (IC 50 ϭ 2.9 M) and inhibited the L-type Ca 2ϩ current (I Ca ) (IC 50 ϭ 4.0 M, maximal inhibition ϭ 69%) to a lesser extent. We conclude that HA-7 blocks multiple ionic currents and that these changes affect the electrophysiological properties of the conduction system as well as the myocardial tissues and may contribute to its antiarrhythmic efficacy.
Atrial and ventricular tachyarrhythmias are believed to play a major role in human morbidity and mortality. Unfortunately, most currently available antiarrhythmic agents are less than ideal in this therapeutic setting. Since the negative outcome of the Cardiac Arrhythmia Suppression Trial (Echt et al., 1991) , class III antiarrhythmics attracted attention and were expected to be more beneficial than class I agents for treatment of life-threatening ventricular tachyarrhythmias and suppressing sudden cardiac death in patients with such risks (Singh and Nademanee, 1985) . In recent years, selective blockers of the cardiac delayed rectifier K ϩ current (I K ), especially the rapid component (I Kr ), have been developed (for a review, see Tamargo et al., 2004) . Although these agents are effective in the termination and prevention of experimentally induced arrhythmias, the therapeutic potential of these drugs in severely sick patients is questionable (Waldo et al., 1996) . Consequently, the search for new types of antiarrhythmic drug to treat malignant cardiac arrhythmias remains an important area of research (Sanguinetti and Bennett, 2003) . Recently, much attention has been focused on the antiarrhythmic drugs with multiple modes of action (i.e., acting on different ion channels and/or receptors), with the expectation that such agents may be more effective for therapy and devoid of serious cardiac side effects (Má tyus et al., 1997; Amos et al., 2001) .
HA-7 is a novel tetrahydrofuroquinoline alkaloid derivative that has been synthesized recently. We previously demonstrated that HA-7 could reverse the cardiac arrhythmias induced by postischemic reperfusion in isolated rat hearts and produce a moderate positive inotropic effect in rat cardiac tissues (Su et al., 1997) . In the same study, it was shown that this antiarrhythmic activity may be related to the predominant blockade of the transient outward K ϩ current (I to ), a major repolarizing current in rat heart (Josephson et al., 1984) , steady-state outward K ϩ current (I SS ), and Na ϩ channels. Thus, HA-7 may exert mixed class I and stronger class III antiarrhythmic properties (Su et al., 1997) . In fact, most of the class III antiarrhythmic agents, such as sotalol, dofetilide, or amiodarone, are known to prolong cardiac APD and suppress re-entrant arrhythmia primarily via the blockade of the I K , which is absent in rat cardiomyocytes but exists prominently as the main repolarizing current in guinea pig (Hume and Uehara, 1985) and human myocardium (Li et al., 1996) . Therefore, the present study was conducted to examine whether HA-7 could also exert antiarrhythmic, electromechanical, and ion channel-modifying actions in guinea pig heart preparations and to compare its effects with those of a typical class III agent d-sotalol (Hohnloser and Woosley, 1994) . In this study, the antiarrhythmic effect of HA-7 was evaluated on both the electrical stimulation-induced atrial fibrillation and the reperfusion-induced ventricular tachyarrhythmias in Langendorff perfused guinea pig hearts. The electrophysiological activity of HA-7 on the conduction system was assessed in perfused isolated hearts, whereas the mechanical and electrophysiological effects of HA-7 were assessed in guinea pig atrial strips and ventricular papillary muscles. Further investigations on ionic currents were also performed using the patch-clamp technique in isolated guinea pig cardiomyocytes.
Materials and Methods
All experiments were performed in accordance with the internationally accepted guidelines. Studies were approved by the Institute Committee of the Animal Care of the University of Chang Gung College of Medicine. Guinea pigs were housed in the animal care facility at the Chang Gung Memorial Hospital (Tao-Yuan, Taiwan). All animals were housed with a 12-h light/dark cycle. Food and water were available ad libitum.
Intracardiac Electrocardiogram-Recording Experiment
Animal Preparation. Adult male Hartly guinea pigs (250 -300 g body weight, purchased from the Laboratory Animal Center of National Taiwan University Hospital) were anesthetized with sodium pentobarbital (50 mg/kg, i.p.) and given heparin (300 units/kg, i.p.). Following anesthesia, the heart was excised via thoracotomy and the ascending aorta was retrogradely perfused at a rate of 4 ml/min/g cardiac tissue with normal Tyrode's solution (Chang et al., 2002) . The solution was continuously gassed with 95% O 2 and 5% CO 2 to give a pH of 7.4 and was maintained at 37°C. To pace the atria, a high right atrial electrode was placed near the junction of the superior vena cava and right atrium. A bipolar electrode consisting of a tungsten spring-soldered silver wire was placed on the endocardium near the apex of the triangle of Koch to record the His bundle electrograms. In the next stage, the tips of the ventricular recording electrode were placed on opposite sides of the epicardium near the ventricular apex, thereby providing a recognizable T wave. In addition, a ventricular pacing electrode was placed on the pericardium near the right ventricular apex. Pacing studies were performed by utilizing a programmable stimulator (DTU 215; Bloom Electrophysiology, Fischer Imaging, Denver, CO). A pacing stimulus of 1 ms in duration and twice the diastolic threshold voltage was applied to the preparation through the bipolar atrial or ventricular electrodes. The electrograms were continuously monitored on an oscilloscope (TDS520D; Tektronix, Beaverton, OR), and pertinent data were recorded on a chart recorder (WindowGraf; Gould Instrument Systems Inc., Cleveland, OH).
Experimental Protocol. An average of four stable cycle lengths of spontaneous heartbeats was taken as the basic cycle length. The right atrium was then paced at a constant rate that was slightly faster than the spontaneous heart rate. At this constant pacing rate, the intra-atrial (sinoatrial conduction interval), AV nodal (AH), and His-Purkinje (His-ventricular conduction interval) conduction times as well as the ventricular repolarization time (VRT) were measured. Incremental right atrial pacing was used to determine the Wenckebach cycle length at which the 1:1 AV nodal conduction pattern was lost. Atrial premature extrastimulation (S 2 ) was then delivered to the high right atrium after a train of constant rate atrial pacing (S 1 S 1 ) for eight beats to obtain the refractory periods of the atria, AV node, and His-Purkinje system. Ventricular effective refractory period was similarly determined using a ventricular extrastimulation study protocol.
Evaluation of Antiarrhythmic Properties
Global Ischemia/Reperfusion-Induced Arrhythmias. The isolated guinea pig heart was retrogradely perfused through the aorta with normal Tyrode's solution at a constant perfusion pressure. A PE60 cannula attached to a side arm of the constant-pressure Langendorff perfusion apparatus was placed in the right atrium. Following a 10-min equilibration period, hearts were administered drug or vehicle for 10 min. After this preischemic period, the aortic cannula was clamped to terminate aortic flow and to institute global no-flow ischemia. Simultaneously with ischemia onset, the right atrial cannula was opened to enable intracavitary superfusion. The rate of atrial superfusion flow was controlled at 6 ml/min to maintain a heart rate of ϳ200 beats/min. The electrograms were recorded from a low atrial and a ventricular recording electrode and were continuously monitored on an oscilloscope, and pertinent data were recorded on a chart recorder. After 30 min, the aortic cannula was unclamped to permit reperfusion, whereas the right atrial superfusion cannula was clamped and the duration and incidence of arrhythmias was recorded. Vehicle or drug was included in the perfusion solution throughout the time after the preischemic period.
Measurement of Atrial Fibrillation Threshold. Previous studies have shown that atrial vulnerability is enhanced by adenosine, which causes shortening of APD and refractoriness (Kabell et al., 1994 ; for a review, see van der Hooft et al., 2004) . We induced AF with a combination of adenosine and electrical stimulation in Langendorff perfused guinea pig hearts. The fibrillating current was generated from a programmable stimulator (DTU 215) and consisted of a train of 50-square wave pulses of 2-ms duration at a frequency of 50 Hz for 1 s. The pulse train was delivered to the right atrium after every eighth basic paced beat. The current was increased gradually from an intensity twice the diastolic threshold. Atrial fibrillation threshold (AFT) was defined as the minimum amount of current required to induce AF, which was sustained for at least 30 s. To avoid damaging the atrial tissue, we did not deliver a current greater than Multiple Cardiac Electrophysiological Effects of HA-7 381 at ASPET Journals on July 9, 2017 jpet.aspetjournals.org 14 mA. If AF could not be induced when the current was increased to 14 mA, the AFT was provisionally determined to be 14.1 mA.
Electromechanical Recordings. Action potentials were recorded from guinea pig cardiac muscle preparations with a conventional intracellular recording technique (Chang et al., 2002) . In brief, the left atrial strip or ventricular papillary muscle was placed in a tissue chamber and perfused at a rate of 20 ml/min with normal Tyrode's solution. The perfusing solution was oxygenated (95% O 2 and 5% CO 2 ) and kept at 37°C with a temperature controller. External stimuli (1-ms duration, 1.5ϫ the diastolic threshold voltage) were delivered at a basic rate of 1 Hz by an electronic stimulator (S88; Grass Instrument Division, Astro-Med, Inc., West Warwick, RI) via bipolar platinum electrodes. Each preparation was stretched to a length at which maximum-developed force was evoked and allowed to equilibrate for at least 1.5 to 2 h before the commencement of the experiments. Transmembrane potentials were amplified with Axoclamp 2B amplifier (Molecular Devices, Sunnyvale, CA), and the mechanical response was measured with a bridge amplifier (Quad Bridge amplifier; ADInstruments Pty Ltd., Castle Hill, Australia). Action potentials and contractions were recorded by a digital recorder (PowerLab/4sp; ADInstruments) via Chart software (version 4.0.2; ADInstruments) for off-line analysis.
Single-Cell Isolation. Single atrial and ventricular cells from adult guinea pigs were enzymatically dissociated as described previously (Isenberg and Klöckner, 1982) . In brief, the excised heart was mounted on a modified Langendorff perfusion system and retrogradely perfused through the aorta with a normal HEPES-buffered Tyrode's solution (pH 7.4) gassed with 100% O 2 and maintained at 37 Ϯ 0.2°C. The perfusion medium was then changed to a nominally Ca 2ϩ -free HEPES-buffered Tyrode's solution. After 5 min, the perfusate was switched to the same solution containing 0.3 mg/ml collagenase (Type II; Sigma-Aldrich, St. Louis, MO) and 0.1 mg/ml protease (Type XIV; Sigma-Aldrich). After a 7 to 15-min digestion, the residual enzyme solution was removed by more than 5-min perfusion with "modified KB medium" (10 mM taurine, 25 mM KCl, 10 mM KH 2 PO 4 , 70 mM glutamate, 0.5 mM EGTA, and 22 mM dextrose titrated to pH 7.4 with KOH) (Isenberg and Klöckner, 1982) . Thereafter, the atrium was separated from the ventricle, and myocytes from both tissues were dispersed and then stored in KB medium for later use. Only quiescent and Ca 2ϩ -tolerant cells with clear striations were used for experiments.
Voltage-Clamp Recording. Whole-cell recordings were performed following the technique described by Hamill et al. (1981) . Atrial or ventricular cells were bathed at room temperature (25-27°C) in a normal Tyrode's solution. Patch electrodes were fabricated from glass capillaries (o.d., 1.5 mm; i.d., 1.0 mm; A-M Systems, Inc., Carlsborg, WA) using a two-stage vertical puller (model PP-830; Narishige, Tokyo, Japan) and Microforge (model MF-830; Narishige). The electrode was 2 to 5 M⍀ when filled with the pipette solution. Membrane currents were recorded using an integrating patch-clamp amplifier (Axopatch 200B; Molecular Devices). Command pulses were generated by a 16-bit D/A converter (Digidata 1320A; Molecular Devices) controlled by the pCLAMP software (version 8.0.2; Molecular Devices). Electrode junction potentials (5-10 mV) were measured and compensated before formation of the pipette-membrane seal. A high-resistance seal (5-10 G⍀) was obtained before the disruption of the membrane patch. Usually, more than 5 min was allowed for adequate cell dialysis after disruption of the membrane patch.
During measurement of K ؉ currents, the L-type Ca 2ϩ currents (I Ca ) were blocked by the addition of 5 M nifedipine to the bathing solution, and Na ؉ and T-type Ca 2ϩ channels were voltage-inactivated by maintaining the holding potential at Ϫ40 mV. To study the effect of HA-7 on I Ks , 5 M E4031 (Sanguinetti and Jurkiewicz, 1990) was used to block I Kr . When the effect on I Kr was measured, 30 M (Ϫ)-[3R,4S]-chromanol 293B (Bosch et al., 1998 ) was used to block I Ks . For measurement of Ca 2ϩ and Na ϩ inward currents, the K ϩ currents were blocked by adding CsCl (2 mM) to the bathing solution and internal dialysis of the cells with Cs ؉ and tetraethylammoniumcontaining pipette solution. I Na was studied in nifedipine (5 M)-containing low Na ؉ Tyrode's solution ([Na ؉ ] ϭ 54 mM, with NaCl replaced by N-methyl-D-glucamine) and dialysis of the cell with Na ؉ -containing (10 mM) Cs ؉ pipette solution. Time-dependent I K amplitude was measured as the difference from the initial instantaneous current after settling of the capacity transient to the final current level during a given voltage step to various test potentials. I K tail current amplitude was measured as the difference from the steady-state holding current level to the peak tail current amplitude. Inward rectifier K ؉ current (I K1 ) was measured as the difference from the zero current level at the end of 200-ms voltage steps. The amplitude of I Na was measured as the peak inward current with respect to the zero current level. The amplitude of I Ca was the difference between the peak inward current and the current at the end of the test pulse. Reduction of both I Ca and I K with time ("rundown") was observed initially after rupture of the membrane patch. The rundown phenomenon was more prominent during the initial 3-to 8-min access of the patch pipette to the interior of the cell with no significant change over 30 min thereafter. When I Ca (evoked at 0 mV) was normalized to the value at 1 min after disruption of membrane patch, it decreased to 83 Ϯ 3, 73 Ϯ 4, 68 Ϯ 4, 69 Ϯ 5, and 67 Ϯ 5% (n ϭ 11) during the subsequent 3, 6, 9, 12, and 18 min, respectively. Similarly, I K tail current (evoked at ϩ60 mV) decreased to 84 Ϯ 4, 72 Ϯ 4, 69 Ϯ 3, 68 Ϯ 5, and 69 Ϯ 6% (n ϭ 13) during the subsequent 3, 6, 9, 12, and 18 min, respectively. Therefore, experiments were performed only on those cells with stable I Ca or I K 10 min after cell rupture. Current recordings were filtered at 10 kHz bandwidth and then sampled at 100 kHz and stored on the hard disk of an IBM-AT-compatible computer using an on-line data acquisition program (Clampex, pCLAMP). The data were analyzed using a pCLAMP software (Clampfit).
Solutions and Drugs. The normal Tyrode's solution contained 137 mM NaCl, 5.4 mM KCl, 1.1 mM MgCl 2 , 11.9 mM NaHCO 3 , 0.33 mM NaH 2 PO 4 , 1.8 mM CaCl 2 , and 11 mM dextrose. The HEPESbuffered Tyrode's solution contained 137 mM NaCl, 5.4 mM KCl, 1.2 mM KH 2 PO 4 , 1.22 mM MgSO 4 , 1.8 mM CaCl 2 , 22 mM dextrose, and 6 mM HEPES titrated to pH 7.4 with NaOH. The internal pipette filling solution contained 120 mM aspartic acid, 20 mM KCl, 1 mM MgCl 2 , 5 mM K 2 ATP, 5 mM sodium creatine phosphate, 0.2 mM NaGTP, 5 mM EGTA, and 10 mM HEPES adjusted to pH 7.2 with KOH. The Cs ϩ -containing pipette solution contained 130 mM CsCl, 5 mM EGTA, 15 mM tetraethylammonium chloride, 5 mM dextrose, and 10 mM HEPES adjusted to pH 7.2 with CsOH. HA-7 was synthesized by our co-investigators Professors S.-C. Kuo and T. Other drugs were dissolved in physiological saline before the start of the experiment. In control experiments, the final concentration of DMSO up to 0.1% produced no significant effect on muscle contractions and electrophysiological parameters of the cells. HA-7 was dissolved in 100% DMSO as a stock solution of the highest concentration of 0.2 M. Final concentrations (0.1, 0.3, 1, 3, 10, 30, and 100 M) of HA-7 were obtained by cumulative adding aliquots of corresponding stock solutions (1, 2, 10, 20, 50, 200, and 200 mM) to the physiological or external solutions to limit the final concentration of DMSO to approximately 0.096%. All of the stock solutions of d-sotalol, an agent with better solubility, were dissolved in 50% DMSO with distilled water. When stock solutions (the highest concentration was 0.2 M) of d-sotalol were given in a cumulative manner to obtain each final concentration from 3 to 300 M, the total amount of DMSO approximated to 0.087%. During the antiarrhythmic experiments, we used stock solutions with different concentrations to obtain an identical final vehicle (DMSO) concentration of 0.06%. Data Analysis. Statistical analysis was made using an analysis of variance (ANOVA) for repeated measures with Dunnett's t test for multiple comparisons. Incidences of arrhythmias were compared by a 2 procedure followed by pairwise comparison by use of a Fisher's exact test. With the exception of incidences of arrhythmias, all of the data are expressed as mean Ϯ S.E.M. Differences at a P Ͻ 0.05 level were considered statistically significant. Concentration-response curves were fitted by an equation of the form,
where E is the effect at concentration C, E max is maximal effect, IC 50 is the concentration for half-maximal block, and n H is the Hill coefficient.
Results
Modification of the Electrophysiological Properties of the Cardiac Conduction System. Intracardiac recording detected the atrial activity, His potential, and ventricular activity (Fig. 1) . Changes in the electrophysiological parameters of the cardiac conduction system in guinea pig hearts after application of HA-7 and d-sotalol are summarized in Table 1 . The basic cycle length was significantly lengthened by HA-7 at a low concentration (10 M), and this effect was concentration-dependent. At higher concentrations (Ն30 M), the conduction through the AV node (AH interval) and the AV nodal Wenckebach cycle length and refractory period were prolonged. Additionally, HA-7 prolonged the atrial refractory period at a concentration of 30 M or higher. At higher concentrations (100 M), the VRT was also prolonged. The conduction interval through the atrial tissue (sinoatrial conduction interval) and the His-Purkinje system (His-ventricular conduction interval) was not significantly affected. In the present experimental protocol, the AV node usually became refractory to premature extrastimulation before the His-Purkinje system became refractory. Therefore, only the functional refractory period of the His-Purkinje system (shortest conducted V 1 V 2 interval) was measured. This was significantly prolonged by HA-7 at a concentration of 30 M or higher. As compared with HA-7, d-sotalol caused less significant effects on the atrial, AV nodal, and His-Purkinje system parameters but caused comparable or greater effects on basic cycle length and VRT. Both HA-7 and d-sotalol tended to prolong the refractory period of the ventricle, although this change did not reach statistical significance. The effect of d-sotalol on some of the parameters only partially reversed during the 60-min washout.
The atrial cycle length-response relations for the negative dromotropic effects (figure not shown) indicated that prolongation of the AH conduction interval caused by HA-7 was greater at faster atrial pacing rates than at slower rates. Such frequency-dependent effects on the AV node could also be observed in the d-sotalol treatment group. HA-7 at 100 M prolonged the AH interval from 64 Ϯ 2 to 80 Ϯ 4 ms (P Ͻ 0.01, n ϭ 9) and from 66 Ϯ 2 to 92 Ϯ 5 ms (P Ͻ 0.001, n ϭ 9) at atrial cycle lengths of 300 and 260 ms, respectively. Equimolar d-sotalol prolonged this parameter from 56 Ϯ 2 to 68 Ϯ 4 ms (P Ͻ 0.05, n ϭ 8) and from 58 Ϯ 2 to 85 Ϯ 10 ms (P Ͻ 0.01, n ϭ 8) at atrial cycle lengths of 300 and 260 ms, respectively.
Antiarrhythmic Testing in Isolated Hearts. In the reperfusion-induced VF model, one group of hearts was used as a vehicle control (0.06% DMSO) group, whereas the other two groups were exposed to either HA-7 or d-sotalol (30 and 100 M). Arrhythmia induced by reperfusion of the globally ischemic heart appeared within 10 to 30 s. There was no significant difference in both the incidence and duration of VF for either compound at 30 M as compared with vehicle controls (Table 2) . When the drug concentration was increased to 100 M, the incidence of VF was significantly reduced in HA-7 but not in d-sotalol group, whereas the VF duration was significantly reduced in both groups. Also, HA-7 caused a more prominent shortening of mean duration of VF than that of d-sotalol.
In the control condition, AF could not be induced by a train of stimuli at an intensity up to 14 mA in Langendorff perfused hearts. After the application of 20 M adenosine, AFT was decreased to approximately 1.5 mA, which was associated with a marked decrease in AERP (Table 3) . The addition of 100 M HA-7 significantly increased AFT and reversed the adenosine-induced decrease in ERP. Our unpublished data showed that this later effect might not be mediated by the blockade of the adenosine receptor. In contrast, the vehicle or d-sotalol had no apparent effect on AFT (Table 3) .
Effects of HA-7 on Action Potentials and Contractile Force in Atrial Strips. The effects of HA-7 (30 and 100 M) superfusion on the action potential in a left atrial strip paced at 1 Hz are shown in Fig. 2a (left panel) . HA-7 at 100 M significantly lengthened the action potential durations measured both at 50 and 90% repolarization (APD 50 and APD 90 ) 
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at ASPET Journals on July 9, 2017 jpet.aspetjournals.org Downloaded from from 36 Ϯ 2 to 48 Ϯ 3 ms (P Ͻ 0.05, ANOVA, n ϭ 8) and from 82 Ϯ 5 to 102 Ϯ 5 ms (P Ͻ 0.05, n ϭ 8), respectively, without causing considerable change in the resting membrane potential (RMP) (control mean value ϭ Ϫ79 Ϯ 2 mV) and the action potential amplitude (APA) (control ϭ 108 Ϯ 1 mV). At the same time, HA-7 (100 M) caused a significant decrease in the maximal rate of depolarization (V max ) from 163 Ϯ 7 to 134 Ϯ 7 V/s (P Ͻ 0.05, n ϭ 8). Concurrent with a prolongation of APD, HA-7 (30 and 100 M) produced an increase in contractile force (CF) (figure not shown) to 160 Ϯ 6 (P Ͻ 0.001, n ϭ 8) and 246 Ϯ 18% (P Ͻ 0.01, n ϭ 8) of the control, respectively. In contrast, d-sotalol had no apparent effect on the action potential parameters and CF in atrial strips at any of the concentrations (10 -100 M) studied. Typical action potential tracings before and after treatment with 100 M d-sotalol were shown in the right panel of Fig. 2a . The APD 50 , APD 90 , and V max values before treatment were 27 Ϯ 2 ms, 67 Ϯ 3 ms, and 136 Ϯ 8 V/s (n ϭ 10), and these values were changed to 31 Ϯ 4 ms, 76 Ϯ 4 ms, and 135 Ϯ 11 V/s, respec- tively (all P Ͼ 0.05, n ϭ 10) after treatment with 100 M d-sotalol. The same concentration of d-sotalol only caused a small increase in CF to 107 Ϯ 6% (P Ͼ 0.05, n ϭ 10) of the control.
Effects of HA-7 on Action Potentials and Contractile Force in Papillary Muscles. In papillary muscles paced at 1 Hz, HA-7 at 100 M caused a moderate but insignificant increase in contractile force (155 Ϯ 17% of the control) (figure not shown) and prolongation of APD 90 (from 186 Ϯ 5 to 201 Ϯ 6 ms, n ϭ 9) (Fig. 2b, left panel) . The higher concentrations of HA-7 (150 M) caused a further increase in CF to 183 Ϯ 29% of the control value (P Ͻ 0.01, n ϭ 9) accompanied by a significant prolongation of APD 90 from 186 Ϯ 5 to 205 Ϯ 5 ms (P Ͻ 0.05, n ϭ 9). HA-7 had a tendency to decrease V max , although this effect did not reach statistical significance. At higher concentrations up to 150 M, HA-7 decreased the V max from 189 Ϯ 9 to 163 Ϯ 14 V/s (P Ͼ 0.05, n ϭ 9). HA-7 produced little change in the RMP (control ϭ Ϫ87 Ϯ 1 mV), APA (control ϭ 122 Ϯ 1 mV), APD 25 , or APD 50 (control ϭ 157 Ϯ 4 ms), although there was a trend for APD 25 to be shortened slightly (from 103 Ϯ 4 to 95 Ϯ 4 ms at 150 M). Despite the small effect on left atrial action potentials, dsotalol had a marked effect on APD of papillary muscles at a stimulation frequency of 1 Hz (Fig. 2c, left Frequency-Dependent Effects of HA-7. To investigate whether HA-7 can exert any use-or frequency-dependent action, we also studied its effects at different stimulation frequencies in papillary muscles. Stimulation frequency was increased sequentially to 0.1, 0.5, 1, 2, and 3 Hz (3 min each), and the steady-state action potentials were recorded before and during the application of HA-7 (30 -150 M) and dsotalol (10 -100 M). Typical action potential tracings obtained at driven rates of 1 and 3 Hz before and after treatment with 100 M HA-7 and d-sotalol are shown in Fig. 2, b and c, respectively. The results for the changes of APD 90 are shown in Fig. 3 . In untreated control groups, when the stimulation frequency was changed from 0.1 to 3 Hz, the APD initially slightly increased and then decreased (Fig. 3, a and  b) , whereas the other parameters, RMP, APA, and V max , were not changed significantly (data not shown). The prolonging effect of HA-7 on APD 90 was similar throughout the pacing frequency range (Fig. 3, a and c); i.e., it did not show true frequency dependence. At a stimulation frequency of 3 Hz, HA-7 (100 and 150 M) significantly lengthened the APD 90 from 140 Ϯ 5 to 158 Ϯ 5 (P Ͻ 0.05, n ϭ 9) and 161 Ϯ 5 ms (P Ͻ 0.05, n ϭ 9), respectively. In contrast, d-sotalol (Ն30 M) caused greater prolongation of APD 90 at lower pacing frequencies (from 0.1 to 1 Hz) than at higher frequencies (Fig. 3, b and d) , indicating that the reverse frequencydependent effect on APD is similar to previous reports (Schmitt et al., 1991) . At a 3-Hz pacing rate, 100 M d-sotalol only slightly prolonged the APD 90 from 115 Ϯ 7 to 132 Ϯ 9 ms (P Ͼ 0.05, n ϭ 8).
Effects of HA-7 on Delayed Outward K ؉ Current. In mammalian species, I K consists of the rapid and slow components, I Kr and I Ks , respectively (Sanguinetti and Jurkiewicz, 1990; Li et al., 1996) . To record I K , the membrane potential of myocytes was held at Ϫ40 mV to inactivate I Na and subsequently depolarized by pulses lasting either 3000 (I Ks ) or 250 ms (I Kr ). Test potentials of depolarization varied between 0 and ϩ60 mV for I Ks but between Ϫ20 and ϩ50 mV for I Kr . The membrane was then repolarized to Ϫ40 mV to record deactivating tail current. Figure 4a shows superimposed current traces in re- Fig. 3 . Concentration-and frequency-dependent effects of HA-7 and d-sotalol on APD 90 recorded from papillary muscles. APD 90 before and during application of HA-7 (a, n ϭ 9) or d-sotalol (b, n ϭ 8) was plotted as a function of stimulation frequency. Frequency dependence of APD 90 was measured at the end of the predrug control period and again after exposure to each drug concentration tested for the cumulative concentration-response curve. c and d, effects of cumulative increases in HA-7 (n ϭ 9) and d-sotalol (n ϭ 8) on percentage change of APD 90 at 0.1-, 0.5-, 1-, 2-, and 3-Hz pacing conditions. Each value represents mean Ϯ S.E.M.
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at ASPET Journals on July 9, 2017 jpet.aspetjournals.org sponse to various depolarizing voltage steps under control conditions and during exposure to and after washout of 3 M HA-7. HA-7 decreased the amplitude of activation currents and the tail currents of I Ks . Average currentvoltage (I-V) relationships for the activation currents and the tail currents recorded before and after additions of 1, 3, and 10 M HA-7 are shown in Fig. 4 , b and c, respectively. Figure 5a shows sample current traces, corresponding to the labeled measurements depicted in Fig. 5b , obtained before, during, and after cumulative application of 3, 10, and 30 M HA-7. Figure 5b is a plot that indicates the time course of the changes in the magnitude of I Ks tail current; this protocol was imposed on the cell every 60 s. From experiments similar to those shown in Fig. 5a , we derived the concentration-response relation for the inhibition of tail current (Fig. 5d ) in which the data are expressed as percentage inhibition of predrug tail amplitude after step depolarizations to ϩ60 mV. HA-7 decreased I Ks,tail in a concentration-dependent manner. Under control conditions (in the presence of E4031), the mean I Ks,tail density was 3.2 Ϯ 0.8 pA/pF (n ϭ 8). The overall data were well described by the Hill equation with a mean IC 50 of 4.8 Ϯ 1.7 M, a coefficient of 0.85 Ϯ 0.10, and a maximal inhibition of 103 Ϯ 5% (n ϭ 8). In comparison with HA-7, d-sotalol produced less effect on I Ks (Fig. 5, c and d) . HA-7 also inhibited the I Ks currents of atrial myocytes (Fig. 7, a  and c) . The mean amplitude of I Ks,tail in atrial myocytes elicited at the test potential of ϩ60 mV was 2.7 Ϯ 0.6 pA/pF (n ϭ 8). The averaged IC 50 for the effect of HA-7 on I Ks,tail was 3.0 Ϯ 1.1 M with a maximal inhibition of 99 Ϯ 3% (n H ϭ 0.84 Ϯ 0.09, n ϭ 8). Figure 6 depicts that HA-7 could also suppress the I Kr currents in guinea pig ventricular myocytes. The superimposed I Kr current traces before and during exposure to and following washout of 1 M HA-7 are shown in Fig. 6a . I Kr tail current density-voltage relationships are plotted in Fig. 6b for control and after application of 0.3, 1, and 3 M HA-7. Concentration-dependent inhibition of HA-7 on I Kr evoked at a test potential of ϩ30 mV was plotted in Fig. 6d . Under control conditions (in the presence of (Ϫ)-[3R,4S]-chromanol 293B), the mean I Kr density was 0.15 Ϯ 0.02 pA/pF (n ϭ 6). The overall data are well described by the Hill equation with a mean IC 50 of 1.1 Ϯ 0.3 M, a coefficient of 1.02 Ϯ 0.14, and a maximal inhibition of 104 Ϯ 3% (n ϭ 6). d-Sotalol also showed a comparable inhibitory effect on the I Kr current (Fig.  6, c and d) . The calculated IC 50 for the effect of d-sotalol on I Kr,tail was 1.7 Ϯ 0.4 M with a maximal inhibition of 107 Ϯ 2% (n H ϭ 1.01 Ϯ 0.12, n ϭ 7). In addition, HA-7 also significantly inhibited I Kr in atrial myocytes (Fig. 7, b and d) . The mean I Kr,tail density in atrial myocytes was 0.44 Ϯ 0.05 pA/pF (n ϭ 6). The calculated IC 50 for the effect of HA-7 on I Kr,tail was 2.1 Ϯ 0.8 M with a maximal inhibition of 114 Ϯ 6% (n H ϭ 0.77 Ϯ 0.17, n ϭ 6).
Effect of HA-7 on Inward Rectifier K ؉ Current. I K1 was elicited by 200-ms long voltage pulses to potentials between Ϫ120 and Ϫ10 mV in 10-mV increments from a holding potential of Ϫ80 mV at a stimulation frequency of 0.1 Hz. Each step was preceded by a prestep to Ϫ40 mV for 200 ms to 
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at ASPET Journals on July 9, 2017 jpet.aspetjournals.org inactivate I Na . Figure 8a gives representative current records from a ventricular myocyte in control and after 5 min of exposure to 30 M HA-7. Steady-state current densities at the end of the test pulse are plotted in Fig. 8b for control and after superfusion of increasing concentrations of HA-7 (1, 3, 10, and 30 M), respectively. The resultant I-V relations had relationships typical of I K1 -V relations, and both inward-and outward-directed currents were diminished by HA-7 in a concentration-dependent manner. At the test potential of Ϫ40 and Ϫ120 mV, 30 M HA-7 reduced I K1 density from the control value of 8.4 Ϯ 2.7 and Ϫ35.7 Ϯ 4.1 pA/pF to 4.3 Ϯ 1.3 (P Ͻ 0.05, n ϭ 6) and Ϫ21.2 Ϯ 2.9 pA/pF (P Ͻ 0.05, n ϭ 6), respectively. In contrast, d-sotalol did not change either the inward or outward I K1 currents, even over the concentration range higher than that of HA-7 (figure not shown). The I K1 density at the test potential of Ϫ120 mV before and after application of 10, 30, 100, and 300 M d-sotalol were Ϫ40.1 Ϯ 3.8, Ϫ41.0 Ϯ 3.8, Ϫ40.2 Ϯ 3.3, Ϫ38.3 Ϯ 3.8, and Ϫ36.3 Ϯ 4.1 pA/pF (n ϭ 6), respectively.
Effects of HA-7 on Inward Na ؉ and L-Type Ca 2؉ Currents. I Na was elicited every 30 s with a step depolarization from Ϫ80 to Ϫ20 mV. Figure 9ai shows the superimposed current traces from typical experiments with 1 and 3 M HA-7. Concentration-dependent inhibition of HA-7 on I Na was shown in Fig. 9aii . Under control conditions, the mean I Na density was 52.1 Ϯ 5.1 pA/pF (n ϭ 9). The calculated IC 50 was 2.9 Ϯ 0.6 M with a maximal inhibition of 108 Ϯ 3% (n H ϭ 1.44 Ϯ 0.23, n ϭ 9). Compared with HA-7, peak I Na was decreased by 2 Ϯ 5, 17 Ϯ 7, 30 Ϯ 8, 35 Ϯ 9, and 45 Ϯ 12% (n ϭ 9) after 3, 10, 30, 100, and 300 M d-sotalol, respectively. HA-7 also inhibited the I Na currents of atrial myocytes. Peak I Na was decreased by 26 Ϯ 5, 69 Ϯ 4, and 92 Ϯ 3% (n ϭ 5) after 1, 3, and 10 M HA-7, respectively. L-type Ca 2ϩ current was recorded every 10 s during a 300-ms long depolarizing test pulses ranging from Ϫ40 to ϩ50 mV. Representative superimposed current traces evoked at 0 mV under control conditions, after treatment with 10 M HA-7 and after washout, are shown in Fig. 9bii , inset. Figure   Fig. 8 . Effects of HA-7 on I K1 in guinea pig ventricular myocytes. a, sample traces used to construct I-V relationships in the absence (control) and after 5-min exposure to 30 M HA-7. Currents were serially elicited (from Ϫ20 to Ϫ120 mV for 200 ms in 10-mV steps) after a prepulse of Ϫ40 mV. Dashed lines indicate zero current level. b, average current densityvoltage relationships of steady-state component of I K1 in control and after 5-min exposure to 1, 3, 10, and 30 M HA-7 (n ϭ 6). 9bi shows the effects of 1 and 3 M HA-7 on the peak I-V relationship. HA-7 reduced peak current amplitude in a concentration-dependent manner but did not alter the shape of the I-V relationships. Figure 9bii shows the concentrationresponse curve for the effect of HA-7 on the peak I Ca . Average control peak current amplitude at 0 mV was 7.9 Ϯ 1.1 pA/pF (n ϭ 8). From these data, an IC 50 value of 4.0 Ϯ 1.5 M and a maximum inhibition of 69 Ϯ 7% were obtained with a Hill slope of 1.12 Ϯ 0.14 (n ϭ 8). In comparison with HA-7, d-sotalol at 3, 10, 30, 100, and 300 M decreased I Ca by 4 Ϯ 5, 11 Ϯ 11, 28 Ϯ 8, 37 Ϯ 9, and 51 Ϯ 13% (n ϭ 8), respectively. HA-7 also moderately inhibited the I Ca currents of atrial myocytes. Peak I Ca was only decreased by 18 Ϯ 6, 34 Ϯ 8, and 49 Ϯ 10% (n ϭ 5) after 1, 3, and 10 M HA-7, respectively.
Discussion
The major findings from this study are as follows. 1) HA-7 prolonged conduction intervals and the refractoriness of the cardiac conduction system. 2) HA-7 lengthened the repolarization in both atrial and ventricular muscles. 3) HA-7 exhibited a lack of reverse frequency-dependent prolongation of APD. 4) HA-7 was more effective than d-sotalol in reducing experimental atrial and ventricular arrhythmias. 5) HA-7 exerted equipotent I Kr -blocking activity as d-sotalol but was more potent on I Ks , I K1 , I Na , and I Ca . Using a typical class III agent d-sotalol as a reference compound, the results of this study demonstrate that a nonselective ion channel blocker HA-7 was more effective in modifying electrophysiological parameters in atrial and ventricular tissue and, by virtue of these changes, HA-7 may possess a higher antiarrhythmic effectiveness than d-sotalol in guinea pig heart.
In this study, the experimental AF could be easily induced by a high-frequency atrial stimulation with low intensity during adenosine perfusion in isolated guinea pig hearts. The shortening of ERP resulting from the activation of adenosineactivated K ϩ current [I K(Ado) ] and the subsequent shortening of APD by adenosine (Watanabe et al., 1996) likely underlies the induction of AF in this study. The dominant mechanism of this atrial arrhythmia is considered to be re-entry (Nattel, 2002) . In general, drugs that lengthen the cardiac APD and refractoriness (i.e., class III agents) should prevent premature excitation of cardiac cells and should suppress the incidence of re-entrant tachyarrhythmias, such as atrial and ventricular fibrillation (Singh and Nademanee, 1985) . Our study has shown that higher concentrations of HA-7 reverted the shortened atrial ERP caused by adenosine toward control levels. The improved suppressive effect of HA-7 compared with d-sotalol on experimental AF in the present model is correlated with the more prominent increase of AERP and atrial APD by HA-7. The mechanism(s) underlying the genesis of the ischemia/ reperfusion-induced lethal arrhythmias (ventricular tachycardia and VF) are complex, but a number of factors have been implicated as potential culprits. These detrimental factors, which mostly occur during early reperfusion, may include the formation of oxygen free radicals, the heterogeneity of tissue injury and recovery, and the subsequent electrophysiological disturbances including the re-entry and enhanced automaticity, such as oscillatory after-potentials (Manning and Hearse, 1984; Pogwizd and Corr, 1987) . In the reperfusion-induced arrhythmia model, HA-7 was applied from the preischemic through the reperfusion period and might cause some pharmacological effects over this period, so that could promptly prevent or ameliorate the arrhythmias that occur early at subsequent reperfusion. The efficacy of HA-7 to reduce both the incidence and mean duration of VF was greater than d-sotalol, perhaps through the prolonging effects on ventricular APD, VRT interval, or ventricular effective refractory period. This may suggests that HA-7 may act via a mechanism that includes the prolongation of repolarization and the subsequent suppression of re-entry-induced ventricular tachyarrhythmias. Additionally, through the blockade of I Na and I Ca , HA-7 may reduce the influx of Fig. 9 . a, effects of HA-7 on I Na in guinea pig ventricular myocyte. ai, superimposed current traces of I Na recorded in the control conditions and after exposure to 1 and 3 M HA-7. I Na was elicited by a 30-ms depolarizing pulse from a holding potential of Ϫ80 to Ϫ20 mV. Dashed lines indicate zero current level. aii, concentration-response curve for the inhibition of I Na by HA-7. Symbols represent mean Ϯ S.E.M. (n ϭ 9). b, effects of HA-7 on I Ca in guinea pig ventricular myocyte. bi, I-V relationships for I Ca recorded under control conditions and during exposure to 1 and 3 M HA-7. Currents were elicited during 300-ms depolarizing pulses ranging from Ϫ40 to ϩ50 mV in 10-mV steps from a holding potential of Ϫ40 mV. 
